Skip to main content
. 2021 Dec 3;9(12):1822. doi: 10.3390/biomedicines9121822

Figure 3.

Figure 3

Effects of omalizumab and benralizumab on the daily number of SABA inhalations. Comparisons were made between baseline and omalizumab, baseline and benralizumab, and omalizumab and benralizumab, respectively. *** p < 0.001; **** p < 0.0001. ns: not significant.